Medical Student Research Program, The Ohio State University College of Medicine, Columbus, OH.
Comprehensive Transplant Center, Department of Surgery, The Ohio State University, Columbus, OH; and.
J Immunol. 2021 Jun 15;206(12):2775-2783. doi: 10.4049/jimmunol.2100082.
CD8 T cells have conventionally been studied in relationship to pathogen or tumor clearance. Recent reports have identified novel functions of CXCR5CD8 T cells that can home to lymphoid follicles, a key site of antibody production. In this review we provide an in-depth analysis of conflicting reports regarding the impact of CXCR5CD8 T cells on antibody production and examine the data supporting a role for antibody-enhancement (B cell "helper") and antibody-downregulation (antibody-suppressor) by CXCR5CD8 T cell subsets. CXCR5CD8 T cell molecular phenotypes are associated with CD8-mediated effector functions including distinct subsets that regulate antibody responses. Co-inhibitory molecule PD-1, among others, distinguish CXCR5CD8 T cell subsets. We also provide the first in-depth review of human CXCR5CD8 T cells in the context of clinical outcomes and discuss the potential utility of monitoring the quantity of peripheral blood or tissue infiltrating CXCR5CD8 T cells as a prognostic tool in multiple disease states.
CD8 T 细胞传统上被研究与病原体或肿瘤清除的关系。最近的报告确定了 CXCR5CD8 T 细胞的新功能,它们可以归巢到淋巴滤泡,这是抗体产生的关键部位。在这篇综述中,我们对关于 CXCR5CD8 T 细胞对抗体产生影响的相互矛盾的报告进行了深入分析,并研究了支持 CXCR5CD8 T 细胞亚群在抗体增强(B 细胞“辅助”)和抗体下调(抗体抑制)方面的作用的数据。CXCR5CD8 T 细胞的分子表型与 CD8 介导的效应功能相关,包括调节抗体反应的不同亚群。共抑制分子 PD-1 等可以区分 CXCR5CD8 T 细胞亚群。我们还首次深入综述了人类 CXCR5CD8 T 细胞在临床结局方面的情况,并讨论了监测外周血或组织浸润的 CXCR5CD8 T 细胞数量作为多种疾病状态的预后工具的潜在效用。